Invicta Medical

Invicta Medical is a private sleep health company headquartered in Santa Clara, California. They are focused on developing a novel treatment for obstructive sleep apnea (OSA), a condition that affects millions worldwide. Recognizing the shortcomings of current therapy options, Invicta Medical aims to offer a more effective and comfortable solution. They have secured $25 million in Series A funding from a syndicate of healthcare investors, enabling them to accelerate the development of their proprietary technology.

Invicta Medical is a company led by experienced professionals in the medical device industry, with a strong track record of success in developing and commercializing innovative products. Their team boasts expertise in areas such as clinical research, engineering, regulatory affairs, and quality assurance. They are committed to providing a better sleep experience for those suffering from OSA and are actively working to bring their innovative therapy to market.

Invicta Medical is a sleep health company focused on developing innovative solutions to treat obstructive sleep apnea (OSA). Their mission is to address the significant global health burden of OSA, which impacts millions of people worldwide and is often underdiagnosed and undertreated. Invicta Medical aims to provide a better option for patients than current, often ineffective, therapies like CPAP, by developing a proprietary, best-in-class treatment that improves sleep quality and overall health.

Invicta Medical promotes a culture focused on innovation and collaboration, driven by a deep commitment to improving the lives of sleep apnea sufferers. The company values a strong work ethic and a results-oriented mindset, evidenced by their experienced leadership team and impressive investor base. Invicta's dedication to developing and commercializing disruptive, best-in-class sleep apnea solutions fosters a sense of purpose and shared mission among its employees.

Invicta Medical does not explicitly state its approach to diversity, equity, and inclusion on its website. Therefore, it is not possible to provide a description of its approach from the available information.